$RLFTF $NRXP DD (opinion) post by Priviledged on Y
Post# of 653
(Total Views: 347)
Posted On: 07/18/2021 3:13:08 PM
$RLFTF $NRXP DD (opinion) post by Priviledged on Yh0 - I continue to hear "noise" on this board saying that RAM has made blunderous decisions and fails to come through with PR at just the right moments.
My friends, RAM has a team of advisors, both medical and business community experts, focused on building a company with an ever increasing pipeline. Realize that RLF was not born as a result of Covid's entry into our world.
GEM committed long before Covid and they believed then that RAM had the leadership qualities to lead "their" company.
GEM today has experienced significant gains through this investment. GEM chose to hold when this stock touched the $.80 Mark.
The strategy for GEM, RAM, and RLF, continues to be a long term strategic investment. Certainly, these players expect to gain monetary value through the development of RLF-100 via the many potential promising treatments that likely are to come.
For those planning to sell on a peak reaction of the market as a result of EUA, understand, the RLF strategy is an emerging growth strategy.
Take time to visit the APR website and view our expanded pipeline and current product offering. This company will most likely(soon) Hit a home run with Aviptadil.
They can be expected to expand their R&D investments to grow this company at an accelerated pace once revenue stream explodes.
GEM believes in their original mission of investment with this company.
GEM also believes in their investment of Aviptadil which they doubled down on with their investment in NRXP.
I believe our money is safe. Currently, many of us are experiencing paper loses. Perhaps, within a couple weeks, those of us planning a long term investment here will be experiencing paper gains, while expecting a continual growth strategy.
That's why I'm invested here. Regardless, of your strategy, I wish you massive success with your investment here. GLTA
My friends, RAM has a team of advisors, both medical and business community experts, focused on building a company with an ever increasing pipeline. Realize that RLF was not born as a result of Covid's entry into our world.
GEM committed long before Covid and they believed then that RAM had the leadership qualities to lead "their" company.
GEM today has experienced significant gains through this investment. GEM chose to hold when this stock touched the $.80 Mark.
The strategy for GEM, RAM, and RLF, continues to be a long term strategic investment. Certainly, these players expect to gain monetary value through the development of RLF-100 via the many potential promising treatments that likely are to come.
For those planning to sell on a peak reaction of the market as a result of EUA, understand, the RLF strategy is an emerging growth strategy.
Take time to visit the APR website and view our expanded pipeline and current product offering. This company will most likely(soon) Hit a home run with Aviptadil.
They can be expected to expand their R&D investments to grow this company at an accelerated pace once revenue stream explodes.
GEM believes in their original mission of investment with this company.
GEM also believes in their investment of Aviptadil which they doubled down on with their investment in NRXP.
I believe our money is safe. Currently, many of us are experiencing paper loses. Perhaps, within a couple weeks, those of us planning a long term investment here will be experiencing paper gains, while expecting a continual growth strategy.
That's why I'm invested here. Regardless, of your strategy, I wish you massive success with your investment here. GLTA
(0)
(0)Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ